Academic Journal

Overnight sleep affects the stability of neuropsychological classification in mild cognitive impairment.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Overnight sleep affects the stability of neuropsychological classification in mild cognitive impairment.
Συγγραφείς: Chang JH; Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA., Latona GJ; Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA., Rizzo M; Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA., Phatak V; Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA., Murman DL; Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Πηγή: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 Jan; Vol. 22 (1), pp. e71128.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Imprint Name(s): Publication: 2020- : Hoboken, NJ : John Wiley & Sons, Ltd.
Original Publication: Orlando, FL : Elsevier, Inc.
Ιατρικοί όροι (MeSH): Cognitive Dysfunction*/classification , Cognitive Dysfunction*/diagnosis , Cognitive Dysfunction*/physiopathology , Cognitive Dysfunction*/psychology , Sleep*/physiology , Neuropsychological Tests*, Humans ; Female ; Male ; Aged ; Actigraphy ; Sleep Duration ; Aged, 80 and over
Περίληψη: Introduction: Reversion to normal cognition in mild cognitive impairment (MCI) is relatively common. This study tested whether total sleep time (TST) and sleep efficiency (SE) on the night before cognitive testing predicts MCI reversion.
Methods: Fifty-eight community-dwelling older adults with MCI (mean age = 75 years) participated. MCI was defined as cognitive performance ≥ 1.5 standard deviation below norms in at least one domain, with preserved daily functioning. Participants completed cognitive testing at baseline and 1-year follow-up, and sleep was objectively measured using actigraphy at baseline. Logistic regression assessed whether prior-night TST and SE predicts reversion, adjusting for age and sex.
Results: Sixteen participants (27.6%) reverted. Shorter prior-night TST was associated with higher odds of reversion, whereas SE showed no significant association. Random night or chronic sleep measures showed no associations.
Discussion: Acute sleep disruption may transiently impair cognition and contribute to MCI misclassification. Sleep screening before testing may improve diagnostic reliability.
Highlights: Shorter total sleep time on the night before cognitive testing was associated with higher odds of mild cognitive impairment (MCI) reversion after 1 year. Sleep efficiency, random-night sleep, and 14-day average sleep showed no significant association with MCI reversion. Single-domain MCI cases were more likely to revert than multi-domain MCI cases, suggesting greater susceptibility to acute factors such as poor sleep. Brief screening of prior-night sleep or actigraphy-derived metrics could help identify low-reliability assessment and improve diagnostic stability in MCI research.
(© 2026 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
References: Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. The lancet. 2006;367:1262‐1270.
Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near‐normal cognition: risk factors and prognosis. Neurology. 2012;79:1591‐1598.
Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic‐vs community‐based cohorts. Arch neurol. 2009;66:1151‐1157.
Ghanem A, Berry DS, Burkes A, et al. Prevalence of and annual conversion rates to mild cognitive impairment and dementia: prospective, longitudinal study of an essential tremor cohort. Ann Neurol. 2024;95:1193‐1204. doi:10.1002/ana.26927.
Manly JJ, Tang M, Schupf N, Stern Y, Vonsattel JG, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63:494‐506. doi:10.1002/ana.21326.
Ganguli M, Fu B, Snitz BE, Hughes TF, Chang CH. Mild cognitive impairment: incidence and vascular risk factors in a population‐based cohort. Neurology. 2013;80:2112‐2120.
Yu H, Tan L, Jiao M,etal. Dissecting the clinical and pathological prognosis of MCI patients who reverted to normal cognition: a longitudinal study. BMC Medicine. 2025;23:260. doi:10.1186/s12916‐025‐04092‐0.
Sachdev PS, Lipnicki DM, Crawford J, et al. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population‐based study. PloS one. 2013;8:e59649.
Overton M, Sjögren B, Elmståhl S, Rosso A. Mild cognitive impairment, reversion rates, and associated factors: comparison of two diagnostic approaches. J Alzheimer's Dis. 2023;91:585‐601. doi:10.3233/JAD‐220597.
Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82:317‐325. doi:10.1212/WNL.0000000000000055.
Teymourian H, Tehrani F, Longardner K, et al. Closing the loop for patients with Parkinson disease: where are we?. Nat Rev Neurol. 2022;18:497‐507.
Katayama O, Lee S, Bae S, et al. Lifestyle changes and outcomes of older adults with mild cognitive impairment: a 4‐year longitudinal study. Arch Gerontol Geriatr. 2021;94:104376.
Makino K, Lee S, Bae S, et al. Diabetes and prediabetes inhibit reversion from mild cognitive impairment to normal cognition. J Am Med Dir Assoc. 2021;22:1912‐1918. e1912.
Trevisan C, Siviero P, Limongi F, Noale M, Maggi S. Health‐related predictors of changes in cognitive status in community‐dwelling older individuals. Front Aging Neurosci. 2022;14:876359. doi:10.3389/fnagi.2022.876359.
Yu H, Tan C, Huang S, Zhang X, Tan L, Xu W. Predicting the reversion from mild cognitive impairment to normal cognition based on magnetic resonance imaging, clinical, and neuropsychological examinations. J Affect Disord. 2024;353:90‐98. doi:10.1016/j.jad.2024.03.009.
Ryczek CA, Rivas R, Hemphill L, et al. Association of favorable cerebrospinal fluid markers with reversion of mild cognitive impairment due to Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2025;37:131‐136. doi:10.1176/appi.neuropsych.20240099.
Moradi K, Faghani S, Abdolalizadeh A, Khomeijani‐Farahani M, Ashraf‐Ganjouei A. Biological features of reversion from mild cognitive impairment to normal cognition: a study of cerebrospinal fluid markers and brain volume. J Alzheimers Dis Rep. 2021;5:179‐186. doi:10.3233/adr‐200229.
Li Z, Heckman MG, Kanekiyo T, et al. Clinicopathologic factors associated with reversion to normal cognition in patients with mild cognitive impairment. Neurology. 2022;98:e2036‐e2045. doi:10.1212/wnl.0000000000200387.
Wüst LN, Capdevila NC, Lane LT, Reichert CF, Lasauskaite R. Impact of one night of sleep restriction on sleepiness and cognitive function: a systematic review and meta‐analysis. Sleep Med Rev. 2024;76:101940.
Alhola P, Polo‐Kantola P. Sleep deprivation: impact on cognitive performance. Neuropsychiatric dis treat. 2007;3:553‐567.
Crowley R, Alderman E, Javadi A, Tamminen J. A systematic and meta‐analytic review of the impact of sleep restriction on memory formation. Neurosci Biobehav Rev. 2024;167:105929.
Lim J, Dinges DF. A meta‐analysis of the impact of short‐term sleep deprivation on cognitive variables. Psychol bull. 2010;136:375.
Belenky G, Wesensten NJ, Thorne DR, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose‐response study. J sleep res. 2003;12:1‐12.
Dinges DF, Pack F, Williams K, et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4‐5 hours per night. Sleep. 1997;20:267‐277.
Miyata S, Noda A, Iwamoto K, Kawano N, Okuda M, Ozaki N. Poor sleep quality impairs cognitive performance in older adults. J sleep Res. 2013;22:535‐541.
Pase MP, Harrison S, Misialek JR, et al. Sleep architecture, obstructive sleep apnea, and cognitive function in adults. JAMA network open. 2023;6:e2325152‐e2325152.
Mander BA, Winer JR, Walker MP. Sleep and human aging. Neuron. 2017;94:19‐36. doi:10.1016/j.neuron.2017.02.004.
Li J, Vitiello MV, Gooneratne NS. Sleep in normal aging. Sleep med clin. 2022;17:161‐171.
Ho PTN, Hoepel SJW, Rodriguez‐Ayllon M, Luik AI, Vernooij MW, Neitzel J. Sleep, 24‐hour activity rhythms, and subsequent amyloid‐β pathology. JAMA neurology. 2024;81:824‐834.
Li P, Gao L, Gaba A, et al. Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community‐based older adults. The Lancet Healthy Longev. 2020;1:e96‐e105.
Shi L, Chen S, Ma M, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta‐analysis. Sleep med rev. 2018;40:4‐16.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch neurol. 1999;56:303‐308.
Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J intern med. 2004;256:240‐246.
Jak AJ, Preis SR, Beiser AS, et al. Neuropsychological criteria for mild cognitive impairment and dementia risk in the Framingham heart study. J Int Neuropsychol Soc. 2016;22:937‐943.
Weintraub S, Besser L, Dodge HH, et al. Version 3 of the Alzheimer Disease Centers’ neuropsychological test battery in the uniform data set (UDS). Alzheimer Dis Assoc Disord. 2018;32:10‐17.
Mayo AM. Use of the functional activities questionnaire in older adults with dementia. Hartford Inst Geriatr Nurs. 2016;13.
Choi L, Liu Z, Matthews CE, Buchowski MS. Validation of accelerometer wear and nonwear time classification algorithm. Med Sci Sports Exerc. 2011;43:357‐364. doi:10.1249/MSS.0b013e3181ed61a3.
Tombaugh TN. Trail making test a and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19:203‐214. doi:10.1016/S0887‐6177(03)00039‐8.
Chai Y, Fang Z, Yang FN, et al. Two nights of recovery sleep restores hippocampal connectivity but not episodic memory after total sleep deprivation. Sci Rep. 2020;10:8774. doi:10.1038/s41598‐020‐65086‐x.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155‐163. doi:10.1016/j.jcm.2016.02.012.
Malek‐Ahmadi M. Reversion from mild cognitive impairment to normal cognition: a meta‐analysis. Alzheimer Dis Assoc Disord. 2016;30:324‐330. doi:10.1097/wad.0000000000000145.
Wickens CD, Hutchins SD, Laux L, Sebok A. The impact of sleep disruption on complex cognitive tasks: a meta‐analysis. Hum factors. 2015;57:930‐946.
Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014;13:1017‐1028.
García A, Angel JD, Borrani J, Ramirez C, Valdez P. Sleep deprivation effects on basic cognitive processes: which components of attention, working memory, and executive functions are more susceptible to the lack of sleep?. Sleep Sci. 2021;14:107‐118. doi:10.5935/1984‐0063.20200049.
Carvalho DZ, Kolla BP, McCarter SJ, et al. Associations of chronic insomnia, longitudinal cognitive outcomes, amyloid‐pet, and white matter changes in cognitively normal older adults. Neurology. 2025;105:e214155.
Kay DB, Buysse DJ, Germain A, Hall M, Monk TH. Subjective–objective sleep discrepancy among older adults: associations with insomnia diagnosis and insomnia treatment. J sleep res. 2015;24:32‐39.
Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Copyright© 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New …; 2005.
Bubu OM, Brannick M, Mortimer J, et al. Sleep, cognitive impairment, and Alzheimer's disease: a systematic review and meta‐analysis. Sleep. 2017;40:zsw032.
Westwood AJ, Beiser A, Jain N, et al. Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia. Neurology. 2017;88:1172‐1179.
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413‐446.
Grant Information: 5R01AG017177-18 National Institutes of Health, National Institute on Aging
Contributed Indexing: Keywords: actigraphy; mild cognitive impairment; mild cognitive impairment reversion; neuropsychology; sleep
Entry Date(s): Date Created: 20260126 Date Completed: 20260630 Latest Revision: 20260805
Update Code: 20260805
PubMed Central ID: PMC12832612
DOI: 10.1002/alz.71128
PMID: 41582314
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1552-5279
DOI:10.1002/alz.71128